Cite
HARVARD Citation
Walker, A. et al. (2019). Structure guided drug design to develop kallikrein 5 inhibitors to treat Netherton syndrome. Bioorganic & medicinal chemistry letters. 29 (12), pp. 1454-1458. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Walker, A. et al. (2019). Structure guided drug design to develop kallikrein 5 inhibitors to treat Netherton syndrome. Bioorganic & medicinal chemistry letters. 29 (12), pp. 1454-1458. [Online].